The biosynthesis and topology of the large envelope protein (L protein) of hepadnaviruses was investigated using the duck hepatitis B virus (DHBV) model, which also allows the study of hepadnavirus morphogenesis in experimentally infected hepatocytes. Results from proteolysis of virus particles and from the analysis of topology and posttranslational modification of L chains synthesized in vivo or in a cell-free system both support the presence of a mixed population of L-protein molecules with their N-terminal pre-S domain located either inside or outside the virus particle. During L biosynthesis and DHBV morphogenesis, pre-S, together with the neighboring transmembrane domain (TM-I), initially remained cytoplasmically disposed and was translocated only posttranslationally. Delayed pre-S translocation into a post-endoplasmic reticulum compartment is also indicated by the absence of glycosylation at a modification-competent pre-S glycosylation site. Major features of L-protein biosynthesis and of the resulting dual topology appear to be conserved between avian and mammalian hepadnaviruses, supporting the model that pre-S domains function in part either as an internal matrix for capsid envelopment or externally as a ligand for cellular receptor binding. However, differences in the mechanisms controlling pre-S translocation were revealed by the results of mutational analyses identifying and characterizing cis-acting determinants in pre-S that delay its cotranslational translocation. Our data from DHBV demonstrate the negative influence of a cluster of positively charged amino acid residues next to TM-I, a motif that is conserved among the avian but absent from mammalian hepadnaviruses. Additional control elements, which are apparently shared between both virus groups and which may serve in chaperone binding, were mapped by deletion analysis in the central part of pre-S.
Mature, enveloped animal viruses are released from infected cells by budding at the cell surface or intracellular membranes. In most viral systems studied, this process has been found to require participation of membrane-inserted virus spike proteins. These provide a docking site for the nucleocapsid, which in turn acts as a scaffold responsible for the curvature of the envelope. In rare cases viral envelope proteins are secreted in the absence of nucleocapsids. Capsid-independent budding is particularly efficient in the case of the hepdnaviruses, in which, as a feature unique to hepadnavirus replication, capsid-free virus-like particles (subviral particles, SVPs) are secreted from the infected hepatocyte in 1,000-fold excess to cosecreted virions.
The hepdnavirus budding process involves the homomeric and heteromeric association of several viral envelope proteins which are expressed from a single pre-S/S open reading frame by differential translation initiation and thus are structurally closely related (Fig. 1A) (for a recent review, see reference 14) . As a result of this gene organization, the small envelope protein, the S protein, encompasses only the extensively membrane anchored S domain common to the two (S and L) or the three (S, M, and L) envelope proteins present in the avian or mammalian hepadnavirus particle, respectively (8) . The S protein, which is well conserved between the hepadnavirus species, is able to independently direct SVP budding and export.
By contrast, the large envelope protein (L protein), which contains N terminally some 180 amino acids of a rather variable pre-S sequence, is not secreted in the absence of coassembling S chains but is instead retained in the endoplasmic reticulum (ER) or a subsequent compartment.
The L protein with its pre-S domain is functionally important for species-specific receptor binding and cellular uptake of the extracellular virus (12, 15) . Consistent with this function, the pre-S domain has been located on the surface of the secreted mature virus particle by serological and biochemical techniques (11, 19, 27) . However, such a surface disposition remained for a long time in conflict with data from genetic analyses of pre-S function in duck hepatitis B virus (DHBV) and hepatitis B virus (HBV), indicating that pre-S was also essential for capsid uptake into the budding virion, a finding demanding a cytosolic exposure of intracellular pre-S. A model reconciling these conflicting data was recently provided in the HBV system by complementary studies from three groups investigating L-protein synthesis and topology using a cell-free system or DNA-transfected cells and pre-S surface disposition in the mature virus particle (2, 3, 18, 20) . Accordingly, the HBV L protein is initially synthesized with a cytoplasmic disposition of the pre-S1 domain, and a fraction of these is posttranslationally translocated across the membrane into a post-ER compartment. The mechanism(s) leading to this highly unconventional split mixed topology and the cellular factors involved remained unknown.
We have addressed some of the questions raised by these initial findings and the general validity of the dual topology model by using the DHBV model. Compared to HBV, this animal model offers several experimental advantages for studying hepadnavirus morphogenesis and envelope protein matu-ration. (i) It allows an investigation of these processes also in experimentally infected hepatocytes, ruling out potential artifacts related to forced overexpression in DNA transfected cells. (ii) Biochemical modifications related to topological alterations of envelope proteins are more easily detected in DHBV, since the avian hepadnaviruses produce only two nonglycosylated envelope proteins, whereas three pairs of differentially glycosylated proteins are produced by the mammalian hepadnaviruses. (iii) Genetically homogeneous DHBV subviral particles can be produced abundantly from infected test animals, and these SVPs have been shown in infection/competition studies to be functionally equivalent to virions with respect to cellular receptor binding (11) . The results which we have now obtained in this system with respect to DHBV maturation and pre-S surface disposition are largely in keeping with those for HBV, thus extending the dual topology model to the phylogenetically distant avian hepadnaviruses. Using the DHBV system, we have also identified and characterized two types of determinants in the pre-S sequence that interfere with premature pre-S translocation.
MATERIALS AND METHODS
DHBV particle purification and Staphylococcus V8 protease digestion. DHBV particles were purified from DHBV-positive duck serum as described previously (12) . Briefly, 8 ml serum was layered on a sucrose step gradient and pelleted onto 70% sucrose in 1ϫ phosphate-buffered saline-1 mM EDTA. SVP-containing fractions were identified by immunodot blot against the L protein, pooled, and further purified on a second sucrose gradient to yield an SVP preparation containing about 0.5 mg of DHBV envelope protein/ml. For the V8 protease protection experiments, 5 l of this preparation was incubated at 37°C for up to 2 h with V8 protease (final concentration, 100 g/ml; final volume, 10 l) in 40 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid), pH 7.0-75 mM KCl-4.5 mM Mg-acetate, either with or without 1% Nonidet P-40 (NP-40). The reaction mixtures were terminated at various times by the addition of a sodium dodecyl sulfate (SDS)-containing protein sample buffer and applied to an SDS-polyacrylamide gel. DHBV L protein and its degradation products were detected by Western blotting, using a monoclonal antibody (MAb) recognizing pre-S amino acids 100 to 105 (MAbs 4F8) (12a). The anti-DHBs MAb used in the experiment shown in Fig. 7 (MAb 7C.12, which recognizes amino acids 106 to 112 [12a] ) was kindly provided by J. Pugh, Fox Chase Cancer Center, Philadelphia, Pa.
Plasmid constructs. Plasmid pMT-DL, used for L-gene expression in transfected cells, contains DHBV DNA nucleotides 727 to 2815, preceeded by a promotor cassette comprising nucleotides Ϫ280 to Ϫ9 of the human metallothionine II A promoter (MT promoter [10] ). This construct predicts transcripts to initiate at DHBV position 730, where DHBV L mRNA initiates in vivo (17) . For L-gene expression in vitro, a DHBV DNA fragment comprising DHBV nucleotides 801 to 2815 was inserted into the expression vector pMT7/AMV downstream of chemically synthesized cassettes specifying a T7 promoter element and an untranslated leader sequence from alfalfa mosaic virus (26) .
In vitro protein synthesis and analysis by endoglycosidase H or trypsin digestion. pMT7 AMV-DL constructs were linearized with NdeI, and RNA was synthesized using T7 RNA polymerase according to standard protocols (23) . In vitro translation of the DHBV L protein was performed in a nuclease-treated reticulocyte lysate in the presence of 20 Ci of [
35 S]methionine according to the protocol of the supplier (Promega). To part of the translation reactions, dog pancreas microsomes (Promega) were added, typically 1.8 l per 25-l reaction mix. The translation product was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) and autoradiography, either directly after trichloroacetic acid (TCA) precipitation or after digestion with endoglycosydase H or trypsin. For trypsin digestion, one-third of the translation mix was adjusted to 100 l with TBS (50 mM Tris [pH 7.5], 150 mM NaCl), then trypsin was added to a final concentration of 100 g/ml and incubated for 30 min on ice and the proteins were precipitated with TCA. For endoglycosidase H digestion, the reaction volume was adjusted to 100 l as above. Then the microsomes were incubated with 1,000 U of endoglycosydase H (Biolabs) in 50 mM sodium citrate-0.1% SDS at 37°C overnight, and the proteins were precipitated with TCA. In both cases the precipitated proteins were resuspended in protein sample buffer and analyzed by SDS-PAGE. The percentage of protease-protected L protein was determined by using a Molecular Dynamics PhosphoImager.
Cell culture, metabolic labeling, and immunoprecipitation. Primary duck hepatocytes (PDH) were prepared and cultured as described previously (22) . Briefly, hepatocytes were isolated by a two-step collagenase perfusion, seeded in 10-cm-diameter dishes, and incubated at 37°C. For metabolic labeling, the cells were washed twice with PBS, starved for 30 min in 5 ml of methionine-free minimal essential medium without fetal calf serum, and then pulse-labeled by the addition of 150 Ci of [ 35 S]methionine per dish. Microsomal membranes were either harvested directly or after a chase, using PDH maintenance medium supplemented with 2 mg of methionine/ml. Transient transfection. LMH cells (4) were transfected with 20 g of plasmid DNA per 10-cm dish, using the calcium phosphate precipitation technique. At 48 h after transfection, the cells were pulse-labeled with [
35 S]methionine and microsomes were prepared as described above. Alternatively, cells were lysed in 1 ml of lysis buffer (10 mM Tris [pH 7.4], 100 mM NaCl, 1 mM EDTA, 1% NP-40) and transferred into an Eppendorf tube, and the cell debris was removed by centrifugation. The supernatant was used for immunoprecipitation with a polyclonal anti-pre-S rabbit serum recognizing several epitopes in the pre-S region.
Preparation of microsomal membranes and analysis for translocated proteins by trypsin digestion. Microsomal membranes were prepared and analyzed as described in reference 2, except that digestion with trypsin was carried out for 30 min on ice. Briefly, cells were washed with 1ϫ TBS and then homogenized in 0.1ϫ TBS by dounce homogenization on ice. The cell debris was removed by centrifugation, and the supernatant was layered on 2.7 ml of 10% sucrose in TBS and spun at 37,000 rpm at 4°C for 30 min in an SW60 rotor (Beckman). The microsome pellet was resuspended in 1ϫ TBS. The sample was split into three parts, which were left untreated, or digested on ice with trypsin in the presence or in the absence of NP-40 for 30 min. After inactivation of the protease with phenylmethylsulfonyl fluoride and aprotinin, the samples were adjusted to a final concentration of 0.5% NP-40 and used for immunoprecipitations as described above.
RESULTS
A dual topology of the DHBV large envelope protein in the mature virus particle. Virus particles which had been separated from serum proteins by sedimentation into a sucrose density gradient were used as starting material to test for the presence of two membrane topologies of DHBV L chains by proteolytic degradation of surface-exposed pre-S domains. The reaction products were resolved by SDS-PAGE and analyzed in Western blots by using a pre-S-specific MAb. In these experiments, as exemplified in Fig. 2 for V8 protease, about half of the 35-kDa L-protein molecules were rapidly cleaved, whereas the other half remained resistant even for extended times. In contrast, all L-protein molecules were degraded within a very short time if the virus particle was disrupted by the addition of the nonionic detergent NP-40. Protection of part of the L chains against protease attack was also observed with several enzymes with different cleavage specificities, such as trypsin, chymotrypsin, and thermolysin (11) . These data indicate that the DHBV SVP contains two populations of L-protein molecules which differ in the surface disposition of their pre-S domains. This is consistent with the notion that a part of the L protein posseses a pre-S inside topology in the mature DHBV particle ( Fig. 1) , comparable to the one recently detected by similar techniques for the human HBV virion (2, 18, 20) .
It should be noted that protease digestion of intact DHBV particles resulted in very few and distinct pre-S cleavage products (in the case of protease V8, shown in Fig. 2 , a single 17-kDa fragment, most likely arose from cleavage at Glu-143 or Glu-147 [6, 11] ). The absence of additional smaller pre-S polypeptides suggests that the surface-exposed pre-S domain possesses a rather distinct tertiary structure which renders the numerous other cleavage sites in pre-S (e.g., 11 glutamic acid residues as potential targets for V8 protease) inaccessible to protease attack.
DHBV pre-S export is delayed and uncoupled from polypeptide synthesis. Evidence from HBV DNA-transfected cells had suggested that the dual L topology observed in the mature HBV particle resulted from a mechanism in which pre-S translocation is delayed and thus is uncoupled from polypeptide synthesis. To test whether such a mechanism was also operating during DHBV morphogenesis and also in infected cells, the kinetics of L-chain maturation was investigated in DHBVinfected PDH. Newly synthesized polypeptides were pulse-labeled with [
35 S]methionine, and microsome-associated L chains were tested, after prior subcellular fractionation, for their resistance to protease digestion as an indication of their luminal disposition. In such experiments, of the L protein synthesized during a 10-min pulse, only 10 to 15% was found to resist protease digestion (Fig. 3, lane 2 ). This fraction increased to about 20% after a 1-h chase (not shown) or to 50% after a 2-h chase (lane 5). No change in the kinetics was observed in the presence of the drug brefeldin A, which blocks exit from the ER and leads to redistribution of cis and medial Golgi markers to the ER (13). These results indicate that the great majority of the DHBV L-protein molecules, although imbedded into the ER membrane through their S domains, do not translocate their pre-S domains cotranslationally, suggesting that pre-S translocation occurs late in the cellular export pathway.
DHBV pre-S is not efficiently translocated in a cell-free system. To obtain further information on the mechanism(s) controlling DHBV L-protein synthesis and maturation, this process was investigated in an in vitro translation system. Radiolabeled DHBV L proteins were synthesized from RNA molecules encoding DHBV L or derivatives thereof (Fig. 4A ) in a reticulocyte lysate system, in the presence or absence of dog pancreas microsomes, and subsequently probed for pre-S export by trypsin digestion. In these experiments, synthesis of the authentic 35-kDa L protein was markedly stimulated by the addition of microsomal membranes (Fig. 4B, lanes 3 and 7) , as expected for a protein using a signal recognition particle-dependent insertion mechanism. When treated with trypsin, the translation product was cleaved to yield a major 18-kDa product (lane 4) which, as shown by its failure to react with a set of pre-S-specific antisera (data not shown), most likely represents the extensively membrane inserted and therefore proteaseprotected S domain. Thus, while the cell-free system readily inserted the S domain of the L protein into the ER membrane, The small (S) and the large (L) envelope proteins are translated from two separate in-phase start codons in the DHBV pre-S/S open reading frame. Consequently, the L protein has an N-terminal extension, the pre-S domain, adding 161 amino acid residues to the shared S domain, thereby increasing the size of the protein from 17 to 35 kDa (14) . Two transmembrane domains in S, TM I and TM II, are indicated. (B) Proposed dual topology of DHBV envelope proteins. About half the L-protein molecules expose their pre-S domain on the particle surface, the others have an internal pre-S domain, with TM I not being inserted into the membrane. The S protein traverses the membrane twice with TM I and TM II, in analogy to HBV. The membrane disposition of an extended hydrophobic region near the C terminus is uncertain at least in DHBV but is shown with the C terminus exposed on the particle surfaces, as generally accepted for HBV (8, 14) .
FIG. 2.
Only part of the pre-S domain in mature DHBV particles is accessible for protease digestion. DHBV particles from duck serum were incubated in the absence (lanes 2 to 5) or presence (lanes 7 to 10) of 1% NP-40 with Staphylococcus aureus V8 protease. The reaction products and controls in the absence of V8 protease (lanes 1 and 6) were analyzed by SDS-PAGE and Western blotting, using a MAb directed against pre-S. Without detergent, only about half the L-protein molecules are digested by V8 and a distinct pre-S reactive fragment of 17 kDa ‫)ء(‬ is produced. The positions of the L protein and of the size markers are indicated.
FIG. 3.
The pre-S domain is cytoplasmically exposed in newly synthesized L-protein chains. DHBV-infected PDH were pulse-labeled for 10 min with [ 35 S]methionine. Microsomes were either prepared directly after the pulse (lanes 1 to 3) or after a further incubation in PDH medium containing an excess of unlabeled methionine (pulse-chase, lanes 4 to 6). The structure of the microsome-associated L-protein chains was probed by trypsin digestion. The microsome preparation was divided into three parts and left either untreated (lanes 1 and 4) or digested with trypsin with (lanes 3 and 6) or without (lanes 2 and 5) 0.5% NP-40. The L chains were immunoprecipitated with a pre-S-specific antiserum and analyzed by SDS-PAGE and autoradiography. it was incompetent in converting the pre-S domain into a translocated, protease-resistant form. This lack of cotranslational pre-S export in vitro is consistent with the result obtained in vivo with the great majority of newly synthesized pulse-labeled L chains.
DHBV pre-S is efficiently translocated and glycosylated if preceeded by a signal sequence. To investigate whether the observed delay in pre-S export was caused by elements blocking completion of an ongoing cotranslational process, experiments were carried out with control constructs in which the L gene was fused N terminally to the DHBV pre-C signal sequence (sigL2, Fig. 4A ) thereby enforcing the initiation of cotranslational pre-S export into the ER lumen. In this context, a major protease-resistent L-protein species was produced in the presence of microsomes, indicating that cotranslational pre-S translocation had occurred (Fig. 4B, lanes 7 and 8) . Its size of about 43 kDa was, however, above the 40 kDa expected from the pre-C/L protein expression construct which was synthesized as a protease-sensitive, untranslocated L species in the absence of microsomes (lane 5) (and also produced as a byproduct in the complete system [lane 7] ). This surprising result is explained if we assume that the pre-S sequence contains a potential glycosylation site which becomes apparent only upon cotranslational import into the ER. The following observations support this interpretation. First, after incubation of the translation products with endoglycosidase H, the molecular size of the protease-resistant protein decreased from 43 kDa to the 40-kDa position of the unmodified, protease-sensitive fusion protein produced in the absence of microsomal membranes (Fig. 4C, lane 6) . Second, glycosylated and protease-resistant L chains were also produced from a second pre-C/pre-S fusion construct (sigL1, Fig. 4A ), in which cleavage by signal peptidase removed the pre-C signal sequence in about half of the translocated and glycosylated chains, thereby creating a more complex pattern of reaction products (Fig. 4C,  lanes 3 and 4) . Finally, as shown below (see Fig. 6 , lanes 7 to 9), coupled translocation and modification of pre-S was also observed in cells transfected with a construct expressing the sigL1 pre-C/pre-S fusion tested above in vitro. We therefore conclude that the size increase of the protease-protected L chains is caused by N glycosylation. The presence of the 43-kDa L species thus provides a second, distinct and sensitive marker for detecting cotranslationally translocated DHBV pre-S domains.
In light of these findings, further analysis of the data from Fig. 4B revealed that pre-S export had occurred, although with low efficiency in the in vitro translation system. The corresponding minor trypsin-resistant L species of 38 kDa was par -FIG. 4 . The DHBV pre-S domain is glycosylated if produced from constructs enforcing cotranslational translocation. (A) Constructs used to program the L-protein synthesis in the in vitro translation system. In sigL1, the first 38 amino acids of the DHBV pre-C region (with the signal cleavage site) are fused to pre-S amino acid 10. In sigL2, the first 32 amino acids of pre-C (without signal cleavage site) are fused to pre-S amino acid 1 via 18 residues that preceed pre-S but that are normally not translated. This construct reflects the structure of a spliced RNA found in DHBV-infected hepatocytes (17) . (B) Wild-type L protein and sigL2 were expressed by using rabbit reticulocyte lysate in the presence (lanes 3 and 7) or absence (lanes 1 and 5) of dog pancreas microsomes. The samples were split and either left untreated or digested with trypsin to probe for the topology of the L protein and analyzed by SDS-PAGE and autoradiography. (C) To identify potentially glycosylated forms of the protein produced by sigL2, half of a reaction mixture was digested with endoglycosidase H (lanes 2, 4, and 6) and analyzed, together with a mock-treated control, by SDS-PAGE and autoradiography. Numbers to the left show the positions of the size standards.
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on September 30, 2017 by guest http://jvi.asm.org/ ticularly prominent after proteolytic elimination of the bulk of the reaction products (Fig. 4B, lane 4) . Furthermore, radiolabeled L chains migrating above the major unglycosylated 35-kDa product were sensitive to endoglycosidase H treatment and were not produced in the absence of microsomes (compare Fig. 4C , lanes 1 and 2, with 4B, lane 1). From these data, we conclude that the DHBV pre-S amino acids themselves do not interfere with the efficient cotranslational translocation of pre-S into the ER lumen.
Removal of lysine residues preceeding TM I facilitates pre-S translocation. The above data suggest that the DHBV pre-S region contains elements interfering with rapid pre-S translocation. A candidate for such an element is a cluster of lysine residues located near the carboxy-terminal end of the pre-S sequence, thus preceeding TM I only in the L protein but not in the ER insertion-competent S protein (Fig. 5A) . In the topological model presented in Fig. 1 , pre-S translocation results in a luminal disposition of these positively charged residues, which is in disagreement with the positive inside rule observed in most transmembrane proteins (TM I), predicting an opposite orientation (7, 16, 25) .
To test this issue directly, we constructed a series of mutant DHBV L genes, in which the relevant four lysines had been sequentially replaced by uncharged amino acids (Fig. 5A) . Each mutant was then translated in the in vitro translocation system, and the products were examined for a size increase indicative of glycosylation and for trypsin protection. The results of this analysis (Fig. 5B) showed that the stepwise removal of lysines correlated with a progressive increase of the fraction of protease-resistant, glycosylated 38-kDa L species. Quantitative evaluation of the data revealed that glycosylated L chains amounted to about 30% in the case of the quadruple mutant T-TTI compared with 6% of glycosylated wild-type L chains. With respect to the fraction of glycosylated membrane-associated L chains, these values represent a lower limit. They probably need to be doubled, considering that only about half of the L chains produced were membrane associated, as is evident from the limited (only 50%) conversion of the translocationcompetent sigL2 protein to a glycosylated, protease-resistant state (Fig. 5, lanes 11 and 12) , a yield generally observed in in vitro translation-translocation experiments.
We next examined whether cotranslational pre-S export was equally influenced in vivo by the presence of the charged lysine residues. To this end, LMH cells were transfected with expression plasmids by using the mouse metallothionine promoter to direct synthesis of DHBV L wild type and the T-TTI replacement mutants, respectively (Fig. 6) . Again, a sigL1 expression construct was included as a positive translocation-competent control. Newly synthesized proteins were pulse-labeled with [ 35 S]methionine as described in the legend to Fig. 3 , and microsome-associated DHBV L chains were examined for protease resistance and glycosylation. As expected, sigL1 directed synthesis of glycosylated and protease-resistant L chains, two subspecies arising from incomplete cleavage of the pre-C signal sequence, as was also observed in the in vitro system. With wild-type L about 10% of the L chains were in a trypsinresistant state after a 10-min pulse, consistent with the result from the pulse-chase experiment with DHBV-infected cells shown in Fig. 3 . There was, at best, only a trace (less than 1%) of the additional 38-kDa glycosylated L protein (gp38), indicating cotranslational pre-S export (lanes 1 and 2) . In contrast, with the T-TTI mutant, the glycosylated L species was present 5, and 8) or presence (lanes 3, 6, and 9 ) of 0.5% NP-40. L-protein chains were precipitated with a pre-S-specific antiserum and analyzed by SDS-PAGE.
as a distinct, protease-resistant polypeptide. Its yield amounted to 6% of the total L chains labeled during the 10-min pulse and was reduced to about 3% after a 1-h chase. Very little, if any, gp38 was detected in the steady-state products present in microsomal membranes at 2 days posttransfection (data not shown). Taken together, these data support the hypothesis that cotranslational pre-S translocation and the accompanying TM I insertion are negatively influenced by the unconventional accumulation of positively charged amino acids upstream of TM I. Stepwise replacement of these residues by uncharged amino acids reduced this interference by up to fivefold both in vitro and in vivo. Due to a higher base level, the enhancement of translocation was however more easily detected in the cellfree system, in which the reaction appears to be less stringently controlled and its products are metabolically stable.
Internal deletions in pre-S facilitate pre-S export. As demonstrated above, the cotranslational pre-S export and concomitant insertion of TM I remained extensively hampered, even after mutational elimination of the four lysine residues next to TM I. This suggests that pre-S contains additional elements that negatively influence cotranslational export. This hypothesis was tested with two L-gene constructs lacking about twothirds of the 161 amino acids in the pre-S sequence (d116 and d128, respectively; Fig. 7A ). The d128 deletion also removes the 134Asn-Gln-Ser137 sequence predicted to be the site of N glycosylation utilized during artificially enforced cotranslational export.
These constructs were tested in the context of the pre-S wild-type sequence and also in combination with the Lys replacement mutants T-KTK and T-TTI. L polypeptides expressed in transfected chicken hepatoma cells were characterized by Western blotting and probed for glycosylation by endoglycosidase H treatment (Fig. 7B) . As expected from the sizes of the deleted pre-S segments, shortened L chains of 22 and 20 kDa were produced from the d116-and the d128 series, respectively. The d116 L protein was accompanied by equal amounts of a second, more slowly migrating species representing a glycosylated L variant, as identified by its sensitivity to endoglycosidase H treatment (Fig. 7, lanes 9 and 10) . As predicted from the pre-S amino acid sequence, a corresponding glycoprotein was not produced from DHBV L d128, confirming that pre-S glycosylation occured at Asn-134 (Fig. 7, lane 3) . The observed glycosylation of about half of the d116 L chains also demonstrates that an internally deleted pre-S domain possesses an increased competence to be cotranslationally translocated into the ER lumen. The fraction of translocated pre-S domains was increased further if the shortening of the pre-S region by d116 was combined with the Lys-replacement mutants, as shown above to independently facilitate pre-S export. In this favorable context, the fraction of glycosylated L chains increased to 75 or 95%, respectively, in constructs in which two (d116/T-KTK) or all four lysines (d116/T-TTI) had been replaced by uncharged amino acid residues (Fig. 7, lanes 11 to 14) . Increased glycosylation was accompanied by a marked reduction in the total yields of L chains, suggesting a decreased stability of the translocated d116 mutant proteins with translocated and glycosylated pre-S domains.
Very similar results were obtained in an analogous combinatorial analysis of L chains produced from pre-S deletion mutant d128. In the absence of a glycosylation marker, the protease resistance of radiolabeled, microsome-associated L chains was used to determine pre-S export, as described in the legend to Fig. 3 . Although more difficult to quantitate, the results obtained by this technique clearly indicated that pre-S translocation was again incomplete in case of the d128-wildtype pre-S sequence, but it was essentially complete if d128 was combined with the T-TTI mutation (24) . Taken together, these results provide strong evidence for the presence of additional determinants interfering with cotranslational pre-S export, determinants which are located in the central part of the pre-S sequence, distal from the lysine cluster next to TM I.
DISCUSSION
In this study, we investigated the biosynthesis and topology of the large hepadnavirus envelope protein by using the avian DHBV system. The resistance to proteolytic attack observed for part of the L chains in the mature virus particle is in full accordance with a mixed topology of pre-S domains located either inside or outside of the mature virion, as predicted by the model deduced for the mammalian HBV (14) . Furthermore, using a variety of techniques and also analyzing experimentally infected hepatocytes, we provide comprehensive evidence that DHBV pre-S is not exported cotranslationally but is initially cytoplasmically disposed together with the neighboring transmembrane domain TM I. These conclusions are also supported by similar results from a recently published independent study of DHBV L-protein topology by Guo and Pugh (6) . While in general agreement with our experimental data and interpretations, those authors also present evidence for the existence of a third L-protein species with intermediate topology, in which a small segment of the internally oriented pre-S domains appears to be exposed to the particle surface and accessible to protease cleavage. While at variance in this particular detail, the results from both studies leave little doubt that the mixed L topology, as originally proposed for the human HBV, is also present in the phylogenetically distant duck virus. In supporting and extending the initial studies with HBV, we therefore conclude that major features of L-protein biosynthesis, as well as the resulting alternative L topologies, are essentially conserved between avian and mammalian hepadnaviruses and consequently that the dual L topology is a generally important structural and functional feature of the hepadnavirus envelope. Thus, it appears that hepadnaviruses, due to the necessity of optimizing the limited information potential of their small genomes, exploit a highly unusual mechanism that allows the use of the same protein domain either at a cytoplasmic/interior location for a matrix-like function in capsid envelopment or with a luminal/exterior disposition as a ligand for receptor binding during host cell attachment.
Our analysis of L-protein biosynthesis was facilitated by the unexpected observation that DHBV pre-S was efficiently N glycosylated in positive controls directing artificially enforced pre-S export. Based on the increased resolution and sensitive detection of glycosylated L chains and on the simple pattern originating from the existence of only two (normally unglycosylated) DHBV envelope proteins, additional observations were made which went so far unnoticed in comparable studies with HBV. In particular, the block to cotranslational pre-S export as detected by pre-S glycosylation and protease resistence was found to be not tightly controlled. In a cell-free translation system in which translocated L chains accumulate in the absence of subsequent steps controlling L-protein maturation and particle formation, about 10% of the pre-S domains were found to be glycosylated. In vivo, by contrast, the corresponding glycosylated L species was present in very minor amounts and initially was only detected in pulse-labeling experiments if analyzed in parallel with pre-S mutants showing enhanced cotranslational pre-S translocation. The relative yields of the glycosylated L proteins (Fig. 7) and their fate in pulse-chase experiments (24) indicate that such prematurely translocated L chains were metabolically unstable, an observation explaining the absence of detectable amounts of glycosylated L protein in mature serum-derived DHBV particles. Another rather puzzling result is our observation that up to 10% of the DHBV L chains synthesized during a 10-min pulse were protease resistant but not glycosylated (Fig. 3) , indicating that the protease protection of this species was not related to complete cotranslational pre-S translocation.
The mechanism(s) controlling delayed and partial pre-S export, and the viral and cellular interaction partners involved, is still far from being understood. As a first step toward characterizing the factors influencing the process, we have shown by mutational analysis the existence of at least two types of elements which apparently interfere independently with premature pre-S translocation and glycosylation. One type, characterized by large internal pre-S deletions, appears to involve several binding sites for the cytosolic chaperone Hsc70, which we have found to be associated with internally oriented pre-S domains in the DHBV SVP (9, 24) . A second type of element shown here to contribute to cytosolic retardation of DHBV pre-S domains is a cluster of four lysine residues at the pre-S C terminus, which supposedly interfers with membrane insertion of the adjacent transmembrane region TM I required for translocation of pre-S. While these four charged amino acids are conserved among the avian hepadnaviruses, their functional significance is further highlighted by the fact that their stepwise replacement by uncharged residues resulted in the progressive increase of cotranslational translocation/glycosylation of the DHBV pre-S domain (Fig. 5 to 7) . Pre-S translocation was essentially complete if replacement of all four lysines was combined with one of the translocation-facilitating internal pre-S deletions discussed above. These data argue that at least two factors contribute to the dual topology of the DHBV L protein: the presence of charged amino acids preceeding TM I and sequences within pre-S which inhibit its translocation either because of size restrictions, the folding state, and/or the binding of cellular factors. Another, yet unexplored, possibility for contributing to a cytosolic disposition of the hepadnavirus pre-S domain may be its modification by phosphorylation. Conceivably, the extra charges in the phosphorylated molecules would interfere with membrane translocation and could thus stabilize the initial cytoplasmic disposition of the pre-S domain (5) . DHBV pre-S phosphorylation is well documented and has been mapped to a serine residue located within the deletions shown here to facilitate pre-S export (22a). Experiments are presently under way to determine the phenotype of DHBV mutants with modified pre-S phosphorylation target sequences.
It is interesting to compare these data from DHBV to what is known about comparably acting cis elements in the HBV pre-S domain. First, it should be noted that only short prolinerich motifs are common between the respective pre-S amino acid sequences. Second, there are no positively charged amino acids upstream of HBV TM I, and the absence of such topological determinants in this region in HBV is also illustrated by the complete translocation (and glycosylation) of the 55 carboxy-terminal pre-S amino acids (the pre-S2 domain) present in the middle HBV envelope protein (M protein; reviewed in references 8 and 14). Finally, deletions removing the N-terminal two-thirds of pre-S, or as few as 30 amino acids in its central region, were found to be sufficient on their own to permit complete HBV pre-S translocation, resulting in glycosylated L chains with M-like topology (1, 20) . There is no experimental evidence indicating serine phosphorylation within this presumed translocation control region. Taken together with our observations from DHBV, these data suggest that of the two types of elements implicated in determining delayed pre-S translocation in DHBV, only the one located in its center appears to be the main factor contributing to the cytosolic retardation of HBV pre-S. As we have recently mapped an Hsc70 binding site in this part of the HBV pre-S domain and have also detected Hsc70 in HBV SVPs (9, 24) , all experimental data from HBV and DHBV appear to be compatible with the hypothesis that the formation of stable complexes with the cytosolic chaperone Hsc70 at particular sites within pre-S may be a major factor contributing to the cytosolic retardation of pre-S domains.
